CytoDyn has entered into an agreement to purchase Progenics Pharmaceuticals' proprietary humanized monoclonal antibody HIV viral-entry inhibitor drug candidate, PRO 140, for $3.5m. Upon successful continued clinical development of PRO ...
Tags: CytoDyn, HIV viral-entry inhibitor drug, humanized monoclonal antibody
Mylan Pharmaceuticals has gained final FDA approval for its abbreviated new drug application (ANDA) for Nevirapine Tablets USP, 200mg and initiated the shipment of the product. The generic version of Boehringer Ingelheim's Viramune is ...
Tags: Mylan pharmaceuticals, ANDA, ARV
Mylan, a pharmaceutical company, has introduced lamivudine film coated tablets, 150mg and 300mg, in the UK and Italy. The generic version of GlaxoSmithKline's Epivir tablets is indicated as part of antiretroviral (ARV) combination therapy ...
Tags: Generic Epivir Tablets, lamivudine film coated tablets, HIV-infected
Walgreens and the US Department of Health and Human Services (HHS) will colloborate to develop medication therapy management (MTM) program to improve outcomes for HIV patients. The multi-year program will study the impact of MTM ...